Republican Rep. Andy Ogles (TN-5) has asked the Department of Health and Human Services to immediately add all FDA-approved epinephrine delivery systems, including autoinjectors and nasal sprays, to the TrumpRx federal prescription pricing program.
In a letter to HHS Secretary Robert F. Kennedy Jr., Ogles said expanding the program to include devices such as EpiPens and their generic equivalents would help reduce out-of-pocket costs for patients with severe allergies.
Ogles cited the high price of existing products — including generic autoinjectors that can cost nearly $300 and newly approved nasal sprays near $199 per twopack — as a financial barrier for many families.
Ogles also shared the announcement on X, tweeting that he is taking action to combat what he called insurance company “scams” targeting allergy patients.
“I have just sent a letter to @SecKennedy asking him to include EpiPens on Trump Rx,” Ogles wrote. “We will bring affordability to Tennesseans.”
Adding epinephrine products to TrumpRx would expand access through direct-to-consumer discounts, protect vulnerable patients, and align with the administration’s goal of making prescription drugs more affordable. The program, launched by former President Donald Trump, is designed to deliver lower prices on critical medications.
